We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.22%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$124M
AUM Growth
+$14.4M
(+13%)
Cap. Flow
+$8.49M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
8.4%
Holding
601
New
263
Increased
50
Reduced
50
Closed
238
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.25M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.25M |
| 3 |
Haemonetics
HAE
|
+$779K |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$759K |
| 5 |
GoDaddy
GDDY
|
+$694K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$858K |
| 2 |
DXC Technology
DXC
|
+$821K |
| 3 |
West Pharmaceutical
WST
|
+$728K |
| 4 |
Southwest Airlines
LUV
|
+$717K |
| 5 |
Howmet Aerospace
HWM
|
+$650K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.52% |
| 2 | Industrials | 13.79% |
| 3 | Consumer Discretionary | 12.99% |
| 4 | Healthcare | 11.5% |
| 5 | Financials | 9.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Gilead Sciences
GILD
$167B
| $474K | 0.38% |
+7,287
| New | +$475K |
|
52
MSCI
MSCI
$45.8B
| $471K | 0.38% |
+1,826
| New | +$445K |
|
|
XLNX
53
DELISTED
Xilinx Inc
XLNX
| $470K | 0.38% |
+4,807
| New | +$452K |
|
54
Lattice Semiconductor
LSCC
$17.2B
| $466K | 0.38% |
+24,359
| New | +$468K |
|
55
AB InBev
BUD
$156B
| $464K | 0.37% |
+5,650
| New | +$471K |
|
56
Insperity
NSP
$1.89B
| $464K | 0.37% |
+5,397
| New | +$470K |
|
|
BLUE
57
DELISTED
bluebird bio
BLUE
| $462K | 0.37% |
406
+210
| +107% | +$228K |
|
58
L3Harris
LHX
$52.5B
| $461K | 0.37% |
2,332
+604
| +35% | +$121K |
|
|
WRI
59
DELISTED
Weingarten Realty Investors
WRI
| $458K | 0.37% |
+14,649
| New | +$448K |
|
|
JHG
60
DELISTED
Janus Henderson
JHG
| $451K | 0.36% |
+18,435
| New | +$439K |
|
61
Camden Property Trust
CPT
$11.2B
| $447K | 0.36% |
+4,211
| New | +$466K |
|
62
Carnival Corporation Ltd
CCL
$36.2B
| $445K | 0.36% |
+8,750
| New | +$391K |
|
63
Kennametal
KMT
$2.57B
| $444K | 0.36% |
+12,045
| New | +$403K |
|
|
DOC
64
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $439K | 0.35% |
+23,197
| New | +$425K |
|
65
Crown Holdings
CCK
$13.1B
| $435K | 0.35% |
+5,991
| New | +$427K |
|
66
Fortinet
FTNT
$118B
| $435K | 0.35% |
20,375
-17,085
| -46% | -$322K |
|
|
PDCE
67
DELISTED
PDC Energy, Inc.
PDCE
| $435K | 0.35% |
+16,622
| New | +$399K |
|
68
Alibaba
BABA
$276B
| $433K | 0.35% |
+2,042
| New | +$383K |
|
69
Ferrari
RACE
$66.3B
| $433K | 0.35% |
+2,615
| New | +$423K |
|
70
Inogen
INGN
$178M
| $428K | 0.34% |
+6,262
| New | +$393K |
|
71
Autodesk
ADSK
$46.1B
| $427K | 0.34% |
+2,328
| New | +$377K |
|
|
SGI
72
Somnigroup International
SGI
$15.3B
| $426K | 0.34% |
+19,576
| New | +$409K |
|
|
HOLX
73
DELISTED
Hologic
HOLX
| $423K | 0.34% |
+8,103
| New | +$403K |
|
|
MOMO
74
Hello Group
MOMO
$886M
| $418K | 0.34% |
+12,484
| New | +$444K |
|
75
Unilever
UL
$134B
| $418K | 0.34% |
+6,503
| New | +$432K |
|
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q4 2019 Portfolio in Review
As of Q4 2019, Fox Run Management held 601 positions worth $124M, up 13% from $110M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Fox Run Management deployed $8.49M of net new capital in Q4 2019, opening 263 new positions and adding to 50 existing holdings. Its largest new stake was Haemonetics: 6,441 shares worth $740K.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Generac Holdings, an estimated $629K trimmed.
- Fox Run Management's largest Q4 2019 buy was Haemonetics: 6,441 shares worth $740K.
- Fox Run Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.25M increase.
- Fox Run Management's biggest Q4 2019 reduction was Generac Holdings, cutting an estimated $629K.
- Fox Run Management fully exited Pfizer in Q4 2019, selling an estimated $858K.
- Fox Run Management's ten largest holdings make up 8.4% of its $124M portfolio in Q4 2019.
- Fox Run Management opened 263 new positions and closed 238 in Q4 2019.
- Fox Run Management's portfolio value rose 13% quarter-over-quarter to $124M.
Based on Fox Run Management's 13F filing for Q4 2019, filed 14 Feb 2020.